Has The Recent Pullback In CorVel (CRVL) Opened A Valuation Opportunity?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
If you are wondering whether CorVel's share price reflects its underlying worth, this article explains what the current valuation may be indicating. CorVel's stock has recently pulled back, with returns of 30.1% over 7 days, 31.9% over 30 days, 26.0% year to date and 58.1% over 1 year. The 3 year return is 18.8% and the 5 year return is 43.2%. Recent attention around CorVel has centered on how the market is reassessing managed care and healthcare services companies, which has put a spotlight on pricing versus fundamentals. This shift in focus has prompted many investors to recheck where CorVel's current share price sits relative to its underlying business performance and balance sheet strength. On our valuation checklist, CorVel scores 4 out of 6. This suggests there are several areas where the shares look potentially cheap and others where the price is closer to what standard models imply. Next we will run through those methods, then finish with an approach to valuation that can give you a more complete picture.
Find out why CorVel's -58.1% return over the last year is lagging behind its peers.
Approach 1: CorVel Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today using a required rate of return, to estimate what the business might be worth right now.
For CorVel, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is $109.66 million. Simply Wall St then projects free cash flow out to 2035, with estimates such as $130.21 million in 2026 and $242.99 million in 2035, and discounts each of those future amounts back to today to reflect risk and the time value of money.
Adding those discounted cash flows together gives an estimated intrinsic value of $95.76 per share. Compared with the current share price, this DCF output implies CorVel is 49.2% undervalued according to this model.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests CorVel is undervalued by 49.2%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.CRVL Discounted Cash Flow as at Feb 2026
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for CorVel.
Approach 2: CorVel Price vs Earnings
For a profitable company like CorVel, the P/E ratio is a straightforward way to link what you pay per share to the earnings the business is currently generating. It helps you see how many dollars of share price the market is placing on each dollar of earnings.
Story Continues
A "normal" or "fair" P/E usually reflects what investors expect for future growth and how much risk they see in those earnings. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth expectations or higher uncertainty can point to a lower P/E.
CorVel currently trades on a P/E of 23.5x, which is in line with the Healthcare industry average of about 23.5x and below the peer group average of 55.0x. Simply Wall St also uses a proprietary "Fair Ratio" for P/E, which is the multiple it would expect based on factors like CorVel’s earnings profile, profit margins, industry, market cap and company specific risks.
This Fair Ratio can be more informative than a basic peer or industry comparison because it adjusts for differences in growth, risk and profitability rather than assuming all companies deserve similar multiples.
Result: ABOUT RIGHTNasdaqGS:CRVL P/E Ratio as at Feb 2026
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 22 top founder-led companies.
Upgrade Your Decision Making: Choose your CorVel Narrative
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which let you attach a clear story to the numbers you are using for fair value, future revenue, earnings and margins.
A Narrative is simply your view of CorVel written into a financial forecast, then linked directly to an estimated fair value so you can see how your assumptions translate into a price.
On Simply Wall St, Narratives live inside the Community page, where millions of investors can set their own assumptions and use the tool without needing a spreadsheet or complex models.
Once you have a CorVel Narrative, you can compare your Fair Value to the current share price to help you decide whether the stock looks attractive, fully priced or expensive relative to your view.
Narratives also update automatically when new information such as earnings reports or major news is added, so your fair value view stays aligned with the latest data instead of going stale.
For example, one CorVel Narrative might assume a relatively conservative outlook and produce a much lower fair value. Another Narrative might use more optimistic revenue and margin assumptions and arrive at a much higher fair value for the same stock.
Do you think there's more to the story for CorVel? Head over to our Community to see what others are saying!NasdaqGS:CRVL 1-Year Stock Price Chart
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CRVL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
View Comments
Google